Anti-hepatitis B surface immunoglobulin reduction in early postoperative period after liver transplantation in hepatitis B virus-positive patients

被引：3
|
作者：
Ishigami, Masatoshi [1 ]
Onishi, Yasuharu [2 ]
Ito, Takashi [2 ]
Katano, Yoshiaki
Ito, Akihiro [2 ]
Hirooka, Yoshiki
Kiuchi, Tetsuya [2 ]
Goto, Hidemi
机构：
[1] Nagoya Univ, Grad Sch Med, Dept Gastroenterol, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Transplant Surg, Nagoya, Aichi 4668550, Japan
来源：
HEPATOLOGY RESEARCH | 2011年 / 41卷 / 12期
关键词：
cost; early preoperative period; anti-hepatitis B surface immunoglobulin; hepatitis B virus; liver transplantation; IMMUNE GLOBULIN; HEPATOCELLULAR-CARCINOMA; LAMIVUDINE MONOTHERAPY; COMBINATION LAMIVUDINE; HBV VACCINATION; RECURRENCE; PROPHYLAXIS; PREVENTION; THERAPY; DISCONTINUATION;
D O I：
10.1111/j.1872-034X.2011.00884.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Aim: We investigated a protocol that lowered the necessary dose of anti-hepatitis B surface immunoglobulin (HBIg) with frequent monitoring of hepatitis B surface antigen (HBsAg) and antibody (HBsAb) levels in the early post-transplant period.
引用
收藏
页码：1189 / 1198
页数：10
相关论文
共 50 条
  • [1] Low-dose anti-hepatitis B immunoglobulin regimen as prophylaxis for hepatitis B recurrence after liver transplantation
    Lee, Wei-Chen
    Chou, Hong-Shiue
    Wu, Tsung-Han
    Cheng, Chih-Hsien
    Lee, Chen-Fang
    Wang, Yu-Chao
    Wu, Ting-Jung
    Chan, Kun-Ming
    TRANSPLANT INFECTIOUS DISEASE, 2019, 21 (06)
  • [2] Hepatitis B immunoglobulin for prevention of hepatitis B virus infection and recurrence after liver transplantation
    Congly, Stephen E.
    Burak, Kelly W.
    Coffin, Carla S.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (04) : 429 - 436
  • [3] Management of hepatitis B virus infection after liver transplantation
    Jimenez-Perez, Miguel
    Gonzalez-Grande, Rocio
    Mostazo Torres, Jose
    Gonzalez Arjona, Carolina
    Javier Rando-Munoz, Francisco
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (42) : 12083 - 12090
  • [4] High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation
    Lee, Eung Chang
    Kim, Seong Hoon
    Lee, Seung Duk
    Park, Hyeongmin
    Lee, Soon-Ae
    Park, Sang-Jae
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (14) : 3803 - 3812
  • [5] Shorter hepatitis B immunoglobulin administration is not associated to hepatitis B virus recurrence when receiving combined prophylaxis after liver transplantation
    Lens, Sabela
    Garcia-Eliz, Maria
    Fernandez, Inmaculada
    Castells, Lluis
    Bonacci, Martin
    Mas, Antoni
    Crespo, Gonzalo
    Buti, Maria
    Prieto, Martin
    Forns, Xavier
    LIVER INTERNATIONAL, 2018, 38 (11) : 1940 - 1950
  • [6] Low incidence of acute rejection in hepatitis B virus positive liver transplant recipients and the impact of hepatitis B immunoglobulin
    Veerappan, Annapoorani
    VanWagner, Lisa B.
    Mathew, James M.
    Huang, Xuemei
    Miller, Joshua
    Lapin, Brittany
    Levitsky, Josh
    HUMAN IMMUNOLOGY, 2016, 77 (04) : 367 - 374
  • [7] Recommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation
    Akarsu, Mesut
    Onem, Soner
    Turan, Ilker
    Adali, Gupse
    Akdogan, Meral
    Akyildiz, Murat
    Aladag, Murat
    Balaban, Yasemin
    Danis, Nilay
    Dayangac, Murat
    Gencdal, Genco
    Gokcan, Hale
    Sertesen, Elif
    Gurakar, Merve
    Harputluoglu, Murat
    Kabacam, Gokhan
    Karademir, Sedat
    Kiyici, Murat
    Idilman, Ramazan
    Karasu, Zeki
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2021, 32 (09): : 712 - 719
  • [8] Long-term outcome of patients with lamivudine after early cessation of hepatitis B immunoglobulin for prevention of recurrent hepatitis B following liver transplantation
    Yuefeng, M.
    Weili, F.
    Wenxiang, T.
    Ligang, X.
    Guiling, L.
    Hongwei, G.
    Wencai, L.
    Xiaoguang, W.
    Wei, M.
    Zhongyi, F.
    CLINICAL TRANSPLANTATION, 2011, 25 (04) : 517 - 522
  • [9] Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective
    Wesdorp, D. J. W.
    Knoester, M.
    Braat, A. E.
    Coenraad, M. J.
    Vossen, A. C. T. M.
    Claas, E. C. J.
    van Hoek, B.
    JOURNAL OF CLINICAL VIROLOGY, 2013, 58 (01) : 67 - 73
  • [10] Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter Study
    De Simone, Paolo
    Romagnoli, Renato
    Tandoi, Francesco
    Carrai, Paola
    Ercolani, Giorgio
    Peri, Eugenia
    Zamboni, Fausto
    Mameli, Laura
    Di Benedetto, Fabrizio
    Cillo, Umberto
    De Carlis, Luciano
    Lauterio, Andrea
    Lupo, Luigi
    Tisone, Giuseppe
    Prieto, Martin
    Loinaz, Carmelo
    Mas, Antoni
    Suddle, Abid
    Mutimer, David
    Roche, Bruno
    Wartenberg-Demand, Andrea
    Niemann, Gabriele
    Boehm, Heike
    Samuel, Didier
    TRANSPLANTATION, 2016, 100 (07) : 1507 - 1512
12345